Literature DB >> 14726228

High growing ability of Vibrio vulnificus biotype 1 is essential for production of a toxic metalloprotease causing systemic diseases in humans.

Hirofumi Watanabe1, Shin-ichi Miyoshi, Tomoka Kawase, Ken-ichi Tomochika, Sumio Shinoda.   

Abstract

Vibrio vulnificus biotype 1, a causative agent of fatal septicemia or wound infection in humans, is known to produce a toxic metalloprotease as an important virulence determinant. V. vulnificus biotype 2 (serovar E), a primary eel pathogen, was found to elaborate an extracellular metalloprotease that was indistinguishable from that of biotype 1. The potential of V. vulnificus biotype 1 for production of the metalloprotease was compared with biotype 2 and other human non-pathogenic Vibrio species (Vibrio anguillarum and Vibrio proteolyticus). When cultivated at 25 degrees C in tryptone-yeast extract broth supplemented with 0.9% NaCl, all bacteria multiplied sufficiently and secreted significant amounts of the metalloprotease. However, at 37 degrees C with 0.9% NaCl, V. anguillarum neither grew nor produced the metalloprotease. In human serum, only V. vulnificus biotype 1 revealed a steady multiplication accompanied with production of the extracellular metalloprotease. This prominent ability of biotype 1 in growth and protease production may contribute to cause serious systemic diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726228     DOI: 10.1016/j.micpath.2003.10.001

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

Review 1.  Biodiversity of vibrios.

Authors:  Fabiano L Thompson; Tetsuya Iida; Jean Swings
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

2.  Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation.

Authors:  George P Tegos; Masahiro Anbe; Changming Yang; Tatiana N Demidova; Minahil Satti; Pawel Mroz; Sumbul Janjua; Faten Gad; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 3.  Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review.

Authors:  Fei Leng; Shilong Lin; Wei Wu; Jincheng Zhang; Jieqiong Song; Ming Zhong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-19       Impact factor: 3.267

Review 4.  The extracellular proteases produced by Vibrio parahaemolyticus.

Authors:  George Osei-Adjei; Xinxiang Huang; Yiquan Zhang
Journal:  World J Microbiol Biotechnol       Date:  2018-05-11       Impact factor: 3.312

5.  A large-scale epidemiological study to identify bacteria pathogenic to Pacific oyster Crassostrea gigas and correlation between virulence and metalloprotease-like activity.

Authors:  Denis Saulnier; Sophie De Decker; Philippe Haffner; Laetitia Cobret; Maeva Robert; Céline Garcia
Journal:  Microb Ecol       Date:  2009-12-11       Impact factor: 4.552

6.  Identification and whole-genome sequencing analysis of Vibrio vulnificus strains causing pearl gentian grouper disease in China.

Authors:  Zun Wu; Yating Wu; Haofeng Gao; Xuexin He; Qiang Yao; Zhanglei Yang; Jinyi Zhou; Linting Ji; Jinwei Gao; Xuying Jia; Yong Dou; Xiaoyu Wang; Peng Shao
Journal:  BMC Microbiol       Date:  2022-08-16       Impact factor: 4.465

7.  Extracellular proteolytic enzymes produced by human pathogenic vibrio species.

Authors:  Shin-Ichi Miyoshi
Journal:  Front Microbiol       Date:  2013-11-18       Impact factor: 5.640

Review 8.  Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections: A Systematic Review and Meta-Analysis.

Authors:  Kuo-Chin Huang; Hsu-Huei Weng; Tien-Yu Yang; Te-Sheng Chang; Tsan-Wen Huang; Mel S Lee
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Accurate diagnosis and treatment of Vibrio vulnificus infection: a retrospective study of 12 cases.

Authors:  Yoshinori Matsuoka; Yukishi Nakayama; Tomoko Yamada; Akira Nakagawachi; Kouichi Matsumoto; Kimihide Nakamura; Kyousuke Sugiyama; Yoshinori Tanigawa; Yoshinobu Kakiuchi; Yoshiro Sakaguchi
Journal:  Braz J Infect Dis       Date:  2013-01-14       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.